President Trump is pushing drugmakers to move production back to the United States. He's upping the ante with tariffs to encourage the shift. But would tariffs on imported drugs be enough?

President Donald Trump’s tariff strategy is less about trade and more about geopolitical blackmail. By refusing to be rushed ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in ...

Health insurers are proposing double-digit price hikes for plans sold through Affordable Care Act marketplaces, as extra federal subsidies for premiums expire at the end of the year and President ...

In addition to measures on copper, the U.S. has discussed making announcements on lumber, chips, critical minerals and drugs ...

Brazil's Supreme Court issued search warrants and restraining orders against former President Jair Bolsonaro on Friday, ...

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in ...

President Donald Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in ...

Meanwhile, Australian Prime Minister Anthony Albanese has resisted U.S. calls for Australia to raise its defense spending ...